Should platelets be radiolabelled in plasma medium?

Area of Science:

• Nuclear Medicine
• Hematology
• Radiopharmacology

Background:

• Platelet labeling with Indium-111 oxine traditionally faces low efficiency in plasma-containing media.
• Plasma-free labeling methods can lead to platelet damage, affecting circulation and liver sequestration.
• Understanding these labeling challenges is crucial for accurate diagnostic imaging.

Purpose of the Study:

• To evaluate the optimal conditions for Indium-111 labeled platelet preparation.
• To compare the effects of plasma-containing versus plasma-free media on platelet labeling efficiency and integrity.
• To explore alternative Indium-111 chelates for improved platelet labeling.

Main Methods:

• Investigation of Indium-111 oxine labeling efficiency in both plasma and plasma-free media.
• Assessment of platelet viability and in vivo behavior following different labeling protocols.
• Evaluation of novel Indium-111 chelates (tropolone, mercaptopyridine-N-oxide) for platelet labeling.

Main Results:

• Indium-111 oxine labeling is less efficient in plasma but preserves platelet integrity.
• Plasma-free labeling with Indium-111 oxine can cause irreversible or reversible platelet damage.
• Newer Indium-111 chelates demonstrate high labeling efficiency in both plasma and plasma-free conditions.

Conclusions:

• Labeling human platelets with Indium-111 oxine in plasma is preferred for clinical use due to efficiency and safety.
• Plasma-free labeling requires careful consideration of potential platelet damage.
• Novel Indium-111 chelates offer a viable alternative for robust platelet labeling in various media.